- This conference will be a virtual event -

Overview

Over the past several decades, cancer therapy has evolved from conventional chemotherapy to targeted agents, immunotherapy, and other novel approaches. To help APPs and other clinicians navigate how these therapies are used to treat solid tumors and hematologic malignancies, Horizon CME has developed “Cancer Therapy Review for Advanced Practice Providers”. In this virtual two-day program, clinicians will gain understanding of the various classes of cancer therapy, their mechanisms of action, safety profiles, and applicability in hematologic malignancies and solid tumors. Participation in this program will provide APPs with the practical knowledge they need to provide support and care for patients with cancer.

Industry Employee** registration is date-based pricing +$400

*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.

If you would like to attend as a Student, please contact [email protected] for further information.

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).

Learning Objectives

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By